Compare VTOL & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VTOL | ATRC |
|---|---|---|
| Founded | 1948 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 2011 | 2005 |
| Metric | VTOL | ATRC |
|---|---|---|
| Price | $40.92 | $28.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $58.00 | $51.17 |
| AVG Volume (30 Days) | 222.7K | ★ 783.1K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.02% | N/A |
| EPS Growth | 34.58 | ★ 74.74 |
| EPS | ★ 0.44 | N/A |
| Revenue | ★ $1,490,512,000.00 | $201,630,000.00 |
| Revenue This Year | $11.64 | $15.27 |
| Revenue Next Year | $5.59 | $12.21 |
| P/E Ratio | $96.91 | ★ N/A |
| Revenue Growth | 5.30 | ★ 15.40 |
| 52 Week Low | $32.43 | $25.36 |
| 52 Week High | $50.38 | $43.18 |
| Indicator | VTOL | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 36.83 | 52.47 |
| Support Level | $40.69 | $28.03 |
| Resistance Level | $42.44 | $30.27 |
| Average True Range (ATR) | 1.25 | 1.16 |
| MACD | 0.02 | 0.14 |
| Stochastic Oscillator | 5.76 | 65.94 |
Bristow Group Inc is the provider of vertical flight solutions. The group provides aviation services to a broad base of offshore energy companies and government entities. Its business comprises three reportable segments: Offshore Energy Services, Government Services, and Other Services. Its customers are in the UK, Norway, the USA, Nigeria, and Others. The offshore energy customers use services to transport personnel to, from and between offshore energy installations. The majority of revenue is generated from Offshore Energy Services.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.